This year’s Main Match included 44,344 offered positions, the most in the program’s history, which is 2.6% more than last year’s total of 43,237.

“Additional studies with larger samples and more detailed measures of ACE severity, frequency, and duration are essential.” – Ying Xiong, PhD, Karolinska Institutet, JAMA Network Open, 2026

“These findings support AMPA receptors as a clinically relevant treatment target in MDD.” – Samantha Yohn, PhD, Neurocrine Biosciences, Psych Congress NP Institute, 2026

“The goal is to advance scientific rigor, cultural inclusivity, and adaptability while ensuring that the DSM remains useful to clinicians and remains a trusted, relevant tool for understanding and treating mental disorders.” – Marketa M. Wills, MD, MBA

“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science

From the perspective of the psychiatrist, the best-case scenario is that antidepressant use is merely a marker for dental implant failure. The worst-case scenario is that antidepressant drugs, especially SSRIs, directly predispose to dental implant failure.